Association of non-alcoholic fatty liver disease and psoriasis: A case-control study at a tertiary care hospital in Pakistan
DOI:
https://doi.org/10.66344/jpad.v31i4.1724Abstract
Objective To compare association of Non-Alcoholic fatty liver disease in psoriatic patients versus age and gender matched healthy controls.
Methods Association of non-alcoholic fatty liver disease in psoriatic patients versus healthy controls was compared. Diagnosis was made on ultrasonography and results were recorded.
Results The prevalence of NAFLD in patients with psoriasis was significantly higher as compared to Controls (52.4% vs. 28.7%). The likelihood of having NAFLD was about 2.5 times greater in patients with PsO than the controls (OR 2.741, 95% CI= 1.53-4.904, p= 0.001). In our study it is more frequently reported in males and those in younger age groups.
Conclusion NAFLD appears to occur more frequently in patients with PsO than in the general population. In our study it is more frequently reported in males and those in younger age groups. Patients of PsO should get screened for NAFLD so that planning of appropriate treatment should be taken into consideration to avoid possible risk related of exacerbation or development of NAFLD.
References
Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci.2019;20(6):1475.1
3. Ortolan A, Lorenzin M, Tadiotto G, Russo FP, Oliviero F, Felicetti M, D’Incà R, Favero M, Piaserico S, Doria A, Ramonda R. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. Clin Rheumatol.2019;38(10):2843-50.
4. Narayanasamy K, Sanmarkan AD, Rajendran K, Annasamy C, Ramalingam S. Relationship between psoriasis and non-alcoholic fatty liver disease. Prz Gastroenterol.2016;11(4):263.
5. Pais R, Barritt 4th AS, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. NAFLD and liver transplantation: current burden and expected challenges. J Hepato.2016;65(6):1245-57.
6. Ganzetti G, Campanati A, Molinelli E, Offidani A. Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: three different diseases on a unique background. World J Cardiol.2016;8(2):120.
7. Awosika O, Eleryan MG, Rengifo-Pardo M, Doherty L, Martin LW, Ehrlich A. A case-control study to evaluate the prevalence of nonalcoholic fatty liver disease among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol.2018;11(6):33.
8. Mantovani A, Gisondi P, Lonardo A, Targher G. Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?. Int J Mol Sci.2016;17(2):217.
9. Llamas-Velasco M, De la Cueva P, Notario J, Martìnez-Pilar L, Martorell A, Moreno-Ramìrez D. Moderate psoriasis: a proposed definition. Actas Dermo-Sifiliográficas (English Edition).2017;108(10):911-7.
10. Ayala-Fontánez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckland, NZ).2016;6:7.
11. Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation.2019; 103(1):22-7.
12. Schön MP. Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front Immunol.2019;10:1764.
13. Madanagobalane S, Anandan S. The increased prevalence of non‐alcoholic fatty liver disease in psoriatic patients: a study from South India. Aust J Dermatol.2012;53(3):190-7.
14. Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol.2009;51(4):758-64.
15. van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, Schouten JN, Nijsten T. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. J Am Acad Dermatol.2014;70(3):517-24.
16. Candia R, Ruiz A, Torres‐Robles R, Chávez‐Tapia N, Méndez‐Sánchez N, Arrese M. Risk of non‐alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta‐analysis. J Eur Acad Dermatol Venereol.2015;29(4):656-62.
17. Carrascosa JM, Bonanad C, Dauden E, Botella R, Olveira-Martín A, Systemic Inflammation in Psoriasis Working Group. Psoriasis and nonalcoholic fatty liver disease. Actas Dermo-Sifiliográficas (English Edition).2017;108(6):506-14.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Rabia Ghafoor, Sorath Sohail, Syeda Mahanum ali
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
